Concepedia

Carl Mieczkowski

CM

4

Publications

313

Citations

4

H-Index

2008

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Carl Mieczkowski is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in molecular recognition, systems immunology, and natural sciences.

ORCID

Top concepts

Publications per year

2008–2022

4

Publications

4

Predicting Antibody Developability Profiles Through Early Stage Discovery Screening

Marc Bailly, Carl Mieczkowski, Veronica Juan et al. · mAbs · 2020 · 206 citations · Full text

Auto‐activation mechanism of the Mycobacterium tuberculosis PknB receptor Ser/Thr kinase

Carl Mieczkowski, Anthony T. Iavarone, Tom Alber · The EMBO Journal · 2008 · 82 citations · Full text

Characterization and Modeling of Reversible Antibody Self-Association Provide Insights into Behavior, Prediction, and Correction

Carl Mieczkowski, Alan C. Cheng, Thierry Fischmann et al. · Antibodies · 2021 · 14 citations · Full text

, , +29

An innovative platform to improve asymmetric bispecific antibody assembly, purity, and expression level in stable pool and cell line development

Yanling Wang, Haoran Qiu, Jeremy Minshull et al. · Biochemical Engineering Journal · 2022 · 11 citations · Full text

Rows per page

1–4 of 4